Disease activity in axial spondyloarthritis after discontinuation of TNF inhibitors therapy

OBJECTIVE: Use of tumour necrosis factor inhibitors (TNFi) has proved to be an important step forward in the treatment of axial spondyloarthritis (axSpA), but the duration of the therapy as well as the management in case of low disease activity (LDA) or remission are not clearly established. Current...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Reumatologia
Main Authors: Sebastian, Agata, Wojtala, Patryk, Lubiński, Łukasz, Mimier, Małgorzata, Chlebicki, Arkadiusz, Wiland, Piotr
Formato: Artigo
Idioma:Inglês
Publicado em: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2017
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5647530/
https://ncbi.nlm.nih.gov/pubmed/29056769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/reum.2017.69775
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados